NCT04798131 fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations Status RECRUITING Phase NA
NCT04787302 PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing Status COMPLETED Phase PHASE1
NCT04783571 Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia Status ACTIVE_NOT_RECRUITING Phase NA
NCT04783285 Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders Status COMPLETED Phase NA
NCT04781179 Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia Status UNKNOWN Phase NA
NCT04779177 Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE1
NCT04767204 The Outcomes Among Persons With Schizophrenia Under the Peer-support Service in Vocational Rehabilitation Program Status COMPLETED Phase NA
NCT04761861 Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia Status WITHDRAWN Phase PHASE2
NCT04742413 A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study. Status TERMINATED Phase N/A
NCT04740944 Salutogenic Approach Based Interview With People With Schizophrenia Status COMPLETED Phase NA
NCT04738123 A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) Status COMPLETED Phase PHASE3
NCT04712734 A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia Status COMPLETED Phase PHASE1
NCT04709224 Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT04681807 Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia Status COMPLETED Phase NA
NCT04659174 An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4) Status COMPLETED Phase PHASE3